Hyaluronate Targeted Solid Lipid Nanoparticles of Etoposide: Optimization and In Vitro Characterization

Table 5

Etoposide loading and release efficiency percent in 24 hours from HA targeted SLNs (𝑛=3).

Formulation code	Loading efficiency (%)	RE24 (%)
C2L1.5DO20	54.76 ± 5.71	52.89 ± 7.06
C1L3SO20	59.76 ± 3.22	65.05 ± 4.11
C1L3DO20	42.56 ± 6.32	59.71 ± 8.17
C2L3DO10	58.31 ± 8.79	57.49 ± 6.92
C1L3SO10	65.70 ± 5.36	69.06 ± 5.62
C1L1.5SO10	66.58 ± 4.56	65.36 ± 4.53
C1L1.5DO20	39.53 ± 7.16	55.22 ± 7.86
C2L1.5SO20	37.84 ± 6.19	54.47 ± 7.26
C1L1.5DO10	40.66 ± 5.52	59.71 ± 6.44
C2L3DO20	53.55 ± 8.49	54.24 ± 7.39
C2L3SO10	43.72 ± 8.27	59.28 ± 6.83
C2L1.5SO10	41.93 ± 4.95	55.35 ± 5.92